Updated time: 2023-06-29 10:33:28
11A-1070815
TW I715156、US 10584120 B1、AU 2019333295、KR 10-2405760、JP 7035275CN、 ZL 2019 8 00555577.3、TW I804339
Through a systematic computer-assisted and structure-based drug design, we have synthesized a series of novel compounds as potential drugs for the treatment of Alzheimer’s disease. This class of compounds has been shown to possess potent activity, good pharmacokinetic properties and high blood brain barrier penetration rate. The compounds have also been proved to significantly reduce the deposition of amyloid plaques in the brain of mouse model of Alzheimer’s disease.
- Novel compounds have better pharmacokinetic properties and higher blood brain barrier penetration rate.
- The compounds have been proved to significantly reduce the deposition of amyloid plaques in the brain of mouse model of Alzheimer’s disease.
- Alzheimer’s disease
Hwei-Jiung Wang, Kai-Fa Huang, Chih-Hao Chen , Chuan Shih,...
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Novel compounds as potential drugs for the treatment of Alzheimer’s disease